Search
DaVita Inc
DVAAdd to Watchlist
210.975USD
+1.295+0.62%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
13.96BMarket Cap
19.29P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.62%
5 Days
+0.58%
1 Month
+6.27%
6 Months
+81.08%
Year to Date
+85.70%
1 Year
+54.06%
Key Figures
211.710Open
213.820High
858.13KVolume
19.29P/E TTM
13.71P/E Dynamic
--Dividend TTM
1.30%Turnover Ratio
209.680Prev. Close
209.950Low
108.87MTurnover
14.91P/E Static
-18.48P/B
0.00%Div Yield TTM
6.33%ROA
202.69052wk High
0.97Volume Ratio
936.34MNet Profit
66.19MShares
10.9395EPS TTM
0.90Beta
635.30%ROE
101.00052wk Low
1.85%Amplitude
26.22%Gross Margin
13.96BMarket Cap
2.87Reward/Risk
1.96%Risk Rate
TradingKey Stock Score of DaVita Inc
Currency: USD Updated: 2026-06-22Key Insights
DaVita Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 21 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 193.73.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
DaVita Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
7°C
Very Low
Very High
Neutral
DaVita Inc Highlights
StrengthsRisks
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Overvalued
The company’s latest PE is 19.17, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 36.02M shares, decreasing 8.30% quarter-over-quarter.
Held by Warren Buffett
Star Investor Warren Buffett holds 23.75M shares of this stock.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
193.730
Target Price
-7.61%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
DaVita Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
DaVita Inc Info
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Ticker SymbolDVA
CompanyDaVita Inc
CEORodriguez (Javier J)
Websitehttps://www.davita.com/
Related Instruments
+0.65%
+1.10%
+3.05%
+0.06%
+0.27%
+0.47%
+1.74%
+1.70%
+0.11%
+2.64%
+0.37%
+2.82%
+3.61%
+1.26%
-0.42%
-0.86%
+2.30%
+0.11%
-0.23%
+2.60%Popular Instruments
73.028
+0.083 (+0.11%)
294.300
-2.710 (-0.91%)
200.040
-8.610 (-4.13%)
4108.590
-2.160 (-0.05%)
670.750
-61.870 (-8.45%)
1961.070
-312.660 (-13.75%)
1051.770
-159.610 (-13.18%)
346.130
-3.550 (-1.02%)
62578.100
+137.400 (+0.22%)
381.610
-23.440 (-5.79%)
FAQs
What is the current price of DaVita Inc (DVA)?
The current price of DaVita Inc (DVA) is 209.77.
What is the symbol of DaVita Inc?
The ticker symbol of DaVita Inc is DVA.
What is the 52-week high of DaVita Inc?
The 52-week high of DaVita Inc is 202.69.
What is the 52-week low of DaVita Inc?
The 52-week low of DaVita Inc is 101.00.
What is the market capitalization of DaVita Inc?
The market capitalization of DaVita Inc is 13.46B.
Is DaVita Inc (DVA) currently rated as Buy, Hold, or Sell?
According to analysts, DaVita Inc (DVA) has an overall rating of signal_hold, with a price target of 193.73.
What is the Earnings Per Share (EPS TTM) of DaVita Inc (DVA)?
The Earnings Per Share (EPS TTM) of DaVita Inc (DVA) is 10.06.
